36 related articles for article (PubMed ID: 15379558)
1. Four human thiopurine s-methyltransferase alleles severely affect protein structure and dynamics.
Rutherford K; Daggett V
J Mol Biol; 2008 Jun; 379(4):803-14. PubMed ID: 18482735
[TBL] [Abstract][Full Text] [Related]
2. Unraveling Allostery in a Knotted Minimal Methyltransferase by NMR Spectroscopy.
Capraro DT; Burban DJ; Jennings PA
J Mol Biol; 2020 Apr; 432(9):3018-3032. PubMed ID: 32135193
[TBL] [Abstract][Full Text] [Related]
3. Transcriptome analysis reveals involvement of thiopurine S-methyltransferase in oxidation-reduction processes.
Šmid A; Štajdohar M; Milek M; Urbančič D; Karas Kuželički N; Tamm R; Metspalu A; Mlinarič-Raščan I
Eur J Pharm Sci; 2024 Jan; 192():106616. PubMed ID: 37865284
[TBL] [Abstract][Full Text] [Related]
4. Thiopurine S-methyltransferase pharmacogenetics: autophagy as a mechanism for variant allozyme degradation.
Li F; Wang L; Burgess RJ; Weinshilboum RM
Pharmacogenet Genomics; 2008 Dec; 18(12):1083-94. PubMed ID: 18820593
[TBL] [Abstract][Full Text] [Related]
5. Differential molecular mechanisms of substrate recognition by selenium methyltransferases, INMT and TPMT, in selenium detoxification and excretion.
Fukumoto Y; Kyono R; Shibukawa Y; Tanaka YK; Suzuki N; Ogra Y
J Biol Chem; 2024 Feb; 300(2):105599. PubMed ID: 38159853
[TBL] [Abstract][Full Text] [Related]
6. Systematic Design of Adenosine Analogs as Inhibitors of a
Zhou J; Horton JR; Menna M; Fiorentino F; Ren R; Yu D; Hajian T; Vedadi M; Mazzoccanti G; Ciogli A; Weinhold E; Hüben M; Blumenthal RM; Zhang X; Mai A; Rotili D; Cheng X
J Med Chem; 2023 Jan; 66(1):934-950. PubMed ID: 36581322
[TBL] [Abstract][Full Text] [Related]
7. Genomewide Analysis of Mode of Action of the
Bhattacharya A; Sharma M; Pakkinathan C; Rosen BP; Leprohon P; Ouellette M
mSystems; 2019 Oct; 4(5):. PubMed ID: 31615876
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of thiopurine methyltransferase (TPMT) and multidrug resistance-associated protein gene 4 (MRP4) on mercaptopurine toxicity.
Liu C; Janke LJ; Yang JJ; Evans WE; Schuetz JD; Relling MV
Cancer Chemother Pharmacol; 2017 Aug; 80(2):287-293. PubMed ID: 28623449
[TBL] [Abstract][Full Text] [Related]
9. One amino acid makes a difference-Characterization of a new TPMT allele and the influence of SAM on TPMT stability.
Iu YPH; Helander S; Kahlin AZ; Cheng CW; Shek CC; Leung MH; Wallner B; Mårtensson LG; Appell ML
Sci Rep; 2017 May; 7():46428. PubMed ID: 28462921
[TBL] [Abstract][Full Text] [Related]
10. Genomewide Approach Validates Thiopurine Methyltransferase Activity Is a Monogenic Pharmacogenomic Trait.
Liu C; Yang W; Pei D; Cheng C; Smith C; Landier W; Hageman L; Chen Y; Yang JJ; Crews KR; Kornegay N; Karol SE; Wong FL; Jeha S; Sandlund JT; Ribeiro RC; Rubnitz JE; Metzger ML; Pui CH; Evans WE; Bhatia S; Relling MV
Clin Pharmacol Ther; 2017 Mar; 101(3):373-381. PubMed ID: 27564568
[TBL] [Abstract][Full Text] [Related]
11. Azathioprine-related myelosuppression in a patient homozygous for TPMT*3A.
Budhiraja P; Popovtzer M
Nat Rev Nephrol; 2011 Jun; 7(8):478-84. PubMed ID: 21712851
[TBL] [Abstract][Full Text] [Related]
12. Structural insights into the mechanism and evolution of the vaccinia virus mRNA cap N7 methyl-transferase.
De la Peña M; Kyrieleis OJ; Cusack S
EMBO J; 2007 Nov; 26(23):4913-25. PubMed ID: 17989694
[TBL] [Abstract][Full Text] [Related]
13. Tertiary structure of thiopurine methyltransferase from Pseudomonas syringae, a bacterial orthologue of a polymorphic, drug-metabolizing enzyme.
Scheuermann TH; Lolis E; Hodsdon ME
J Mol Biol; 2003 Oct; 333(3):573-85. PubMed ID: 14556746
[TBL] [Abstract][Full Text] [Related]
14. S-adenosylmethionine regulates thiopurine methyltransferase activity and decreases 6-mercaptopurine cytotoxicity in MOLT lymphoblasts.
Milek M; Karas Kuzelicki N; Smid A; Mlinaric-Rascan I
Biochem Pharmacol; 2009 Jun; 77(12):1845-53. PubMed ID: 19428339
[TBL] [Abstract][Full Text] [Related]
15. The 2.2 A structure of the rRNA methyltransferase ErmC' and its complexes with cofactor and cofactor analogs: implications for the reaction mechanism.
Schluckebier G; Zhong P; Stewart KD; Kavanaugh TJ; Abad-Zapatero C
J Mol Biol; 1999 Jun; 289(2):277-91. PubMed ID: 10366505
[TBL] [Abstract][Full Text] [Related]
16. Thiopurine S-methyltransferase pharmacogenetics: insights, challenges and future directions.
Wang L; Weinshilboum R
Oncogene; 2006 Mar; 25(11):1629-38. PubMed ID: 16550163
[TBL] [Abstract][Full Text] [Related]
17. Drug methylation in cancer therapy: lessons from the TPMT polymorphism.
Krynetski E; Evans WE
Oncogene; 2003 Oct; 22(47):7403-13. PubMed ID: 14576848
[TBL] [Abstract][Full Text] [Related]
18. Consequences of binding an S-adenosylmethionine analogue on the structure and dynamics of the thiopurine methyltransferase protein backbone.
Scheuermann TH; Keeler C; Hodsdon ME
Biochemistry; 2004 Sep; 43(38):12198-209. PubMed ID: 15379558
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
